Journals / Anadolu Kardiyoloji Dergisi / 2002 / Cilt: 2 - Sayı: 3

Assesment of cases with syncope due to primary pulmonary hypertension

Senkopla başvuran bir olgu nedeniyle primer pulmoner hipertansiyonlu olguların değerlendirilmesi

Pages
231–236
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article we aimed to examine this subject by interpreting a patient referred to our clinic for syncope and diagnosed as primary pulmonary hypertension

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary pulmonary hypertension is an uncommon disease.
📊
Key Findings & Data:Its diagnosis is suspected after clinical examination however it can be made only after detailed evaluation of heart and lungs and exclusion of all etiologies for secondary pulmonary hypertension.
💡
Conclusion & Impact:In this article we aimed to examine this subject by interpreting a patient referred to our clinic for syncope and diagnosed as primary pulmonary hypertension
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary pulmonary hypertension is an uncommon disease. Its diagnosis is suspected after clinical examination however it can be made only after detailed evaluation of heart and lungs and exclusion of all etiologies for secondary pulmonary hypertension. Prognosis in general is poor but it ranges individually. In this article we aimed to examine this subject by interpreting a patient referred to our clinic for syncope and diagnosed as primary pulmonary hypertension

Özet

Primer pulmoner hipertansiyon, oldukça nadir görülen bir tablodur. Klinik muayene ile şüphe edilir ancak, teşhisi ayrıntılı kalp ve akciğer incelemesinden ve pulmoner hipertansiyonun sekonder formlarının ekarte edilmesinden sonra kesinleşir. Prognoz, bireyden bireye değişmekle birlikte genelde kötüdür. Bu yazıda, kliniğimize senkop ile başvuran ve primer pulmoner hipertansiyon tanısı konan olgu nedeniyle konunun irdelenmesi amaçlanmıştır.

🔖

Cite This Article

ÖZÇELİK, F., KARAHASANOĞLU, E., KALDIR, H. M., AKTAŞ, Z., ÖZBAY, G., TATLI, E. (2022). Assesment of cases with syncope due to primary pulmonary hypertension. Anadolu Kardiyoloji Dergisi, Cilt: 2 - Sayı: 3, 231–236. https://ajindex.com/articles/437558

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998
  2. Nootens M, Wolfkiel CJ, Chomka EV, Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 1995
  3. Abenhaim L, Moride Y, Rich S, et al. The International Primary Pulmonary Hypertension Study. Chest 1994
  4. 37S. 4.Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor II gene. Am J Hum Genet 2000
  5. Abenhaim L, Moride Y, Brenot F, et al. For the international Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996
  6. Kleiger R, Boxer M, Inghaim RE, Harrison DC. Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest 1976
  7. Rubin L. Primary pulmonary hypertension: ACCP consensus statement. Chest 1993
  8. Moser KM, Daily PO, Peterson K, et al. Thromboendarterectomy for chronic, major vessel thromboembolic pulmonary hypertension: immediate and long term results in 42 patients. Ann Intern Med 1987
  9. Weitzenblum E, Krieger J, Apprill M, et al. Day time pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988
  10. Martos A, Carratala J, Cabellos C, Rodriguez P. AIDS and primary pulmonary hypertension. Am Heart J 1993
  11. Speich R, Jenni R, Opravil M, Pfab M, Russ EW. Primary pulmonary hypertension in HIV infection. Chest 1991
  12. Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension. Chest 1997
  13. D’Alonzo G, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991
  14. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995
  15. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992
  16. Barst RJ, Rubin LJ, Long WA,et al. The Primary Pulmonary Hypertension Study Group. A comparison of continuo